Contact Information
Phone: 804-827-4617
Office: 1112 East Clay Street, Suite B-08
E-mail: teissenb@vcu.edu
Web site: Research Lab
Research Interests
My primary area of research is the behavioral pharmacology of drugs of abuse, focusing primarily on nicotine/tobacco. My current work, funded by the U.S. NIH, involves 1) developing laboratory methods to evaluate potential reduced exposure products (PREPs) for tobacco users, and 2) understanding the knowledge, beliefs, attitudes, and effects of waterpipe tobacco smoking. In addition, I try to promote the responsible conduct of research, particularly with regard to interactions between local Investigational Review Boards (IRBs) and behavioral scientists. I have served on VCU's IRB since August, 2000. I recently chaired the American Psychological Association's Presidential Task Force on IRBs and Psychological Science, and currently chair the American Psychological Association's Committee on Human Research and am a member of the Society for Research on Nicotine and Tobacco's Policy Committee.
Selected Publications
Blank, M. D., & Eissenberg, T. (2010). Evaluating oral, non-combustible potential reduced exposure products for smokers. Nicotine and Tobacco Research, 12, 336-343.
Cobb, C., Ward, K. D., Maziak W., Shihadeh A. L., & Eissenberg T. (2010). Waterpipe tobacco smoking: An emerging health crisis in the United States. American Journal of Health Behavior, 34, 275-285.
Eissenberg, T. (2010). Electronic "cigarettes": Ineffective nicotine delivery and craving suppression after acute administration. Tobacco Control, 19, 87-88.
Eissenberg, T., & Shihadeh, A. (2009). Waterpipe tobacco and cigarette smoking: Direct comparison of toxicant exposure. American Journal of Preventive Medicine, 37, 518-523.
Primack, B. A., Walsh M., Bryce, C., & Eissenberg, T. (2009). Waterpipe tobacco smoking among middle and high school students in Arizona. Pediatrics, 123, e282-8.
Recent Courses Taught at VCU
- Grant Writing, graduate level
Recent Grants
FIC (R03 TW008371), "Waterpipe tobacco smoking: trends, toxicants, and capacity building in Jordan." Start date: September, 2009. Duration: 3 years. Direct costs: $150,000. Principal Investigator.
NCI (R01 CA120142), "Waterpipe tobacco smoke: Toxicant exposure and effects." Start date: February, 2008. Duration: 5 years. Direct costs: $2,307,038. Principal Investigator.
NIDA (R13 DA016409), "Society for Research on Nicotine and Tobacco Annual Meeting." Start date: January, 2008. Duration: 5 years. Direct costs: $404,707. Principal Investigator.
NIDA (R01 DA024876), "Responding to the changing tobacco epidemic in the Eastern Mediterranean Region." Start date: July, 2008. Duration: 5 years. Direct costs: $1,575,950. Co-Investigator.
NCI (R01 CA103827), "Clinical models for evaluating PREPs for tobacco users." Start date: February, 2004. Duration: 5 years. Direct costs: $1,455,400. Principal Investigator.
Recent Sponsored Student Grants
NIDA, (F31 DA028102), "Evaluating the acute effects of caffeinated waterpipe tobacco" (C. Cobb, PI). Start date: February, 2010. Duration: 2 years.
NIDA, (F31 DA018447), "Does puff topography measurement alter smoking behavior?" (M. Blank, PI). Start date: September, 2004. Duration: 3 years.
NIDA, (F31 DA017437), "Tobacco abstinence-induced cognitive decrements." (B. A. Kleykamp, PI). Start date: September, 2003. Duration: 4 years.
NIDA, (F31 DA015570), "Evaluating Risk Reduction Products for Smokers." (A. Breland, PI). Start date: August, 2002. Duration: 3 years.
Recent Awards
- VCU College of Humanities and Sciences Distinguished Scholar Award, 2011
- Joseph Cochin Young Investigator Award, College on Problems of Drug Dependence, 2005